Aliases & Classifications for Scalp Dermatosis

MalaCards integrated aliases for Scalp Dermatosis:

Name: Scalp Dermatosis 12 15
Scalp Dermatoses 44 73
Dermatosis of Scalp 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3136
MeSH 44 D012536
SNOMED-CT 68 402694007
UMLS 73 C0036271

Summaries for Scalp Dermatosis

MalaCards based summary : Scalp Dermatosis, is also known as scalp dermatoses, and has symptoms including exanthema and pruritus. An important gene associated with Scalp Dermatosis is CGA (Glycoprotein Hormones, Alpha Polypeptide). The drugs Petrolatum and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include skin and bone.

Related Diseases for Scalp Dermatosis

Symptoms & Phenotypes for Scalp Dermatosis

UMLS symptoms related to Scalp Dermatosis:


exanthema, pruritus

Drugs & Therapeutics for Scalp Dermatosis

Drugs for Scalp Dermatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 38)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Petrolatum Approved, Investigational Phase 4 8009-03-8
2
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
3
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
4
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
5 Bone Density Conservation Agents Phase 4
6 Calcineurin Inhibitors Phase 4
7 Calcium, Dietary Phase 4
8 Dermatologic Agents Phase 4
9 Emollients Phase 4
10 Immunosuppressive Agents Phase 4
11 Micronutrients Phase 4,Phase 2,Phase 3,Not Applicable
12 Trace Elements Phase 4,Phase 2,Phase 3,Not Applicable
13 Vasoconstrictor Agents Phase 4
14 Vitamins Phase 4
15
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
16
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 22916-47-8 4189
17
Griseofulvin Approved, Investigational, Vet_approved Phase 3,Not Applicable 126-07-8 441140
18
Terbinafine Approved, Investigational, Vet_approved Phase 3 91161-71-6 5402 1549008
19
Albendazole Approved, Vet_approved Phase 2, Phase 3 54965-21-8 2082
20 Papaya Approved, Nutraceutical Phase 2, Phase 3
21 Antifungal Agents Phase 3,Phase 2,Not Applicable
22 Anti-Infective Agents Phase 3,Phase 2,Not Applicable
23 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
24 Cytochrome P-450 Enzyme Inhibitors Phase 3,Not Applicable
25 Hormone Antagonists Phase 3,Not Applicable
26 Hormones Phase 3,Not Applicable
27 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Not Applicable
28 Steroid Synthesis Inhibitors Phase 3,Not Applicable
29 Anthelmintics Phase 2, Phase 3
30 Antimitotic Agents Phase 2, Phase 3
31 Antiparasitic Agents Phase 2, Phase 3
32 Antiprotozoal Agents Phase 2, Phase 3
33
Ciclopirox Approved, Investigational Not Applicable 29342-05-0 2749
34
Ketoconazole Approved, Investigational Not Applicable 65277-42-1 47576 3823
35
Selenium Approved, Investigational, Vet_approved Not Applicable 7782-49-2
36 Antioxidants Not Applicable
37 Cytochrome P-450 CYP3A Inhibitors Not Applicable
38 Protective Agents Not Applicable

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba Completed NCT01388517 Phase 4 Tacrolimus;Calcitriol;Petrolatum
2 A Study Of Diflucan In Children With Ringworm Of The Scalp Completed NCT00645242 Phase 3 fluconazole
3 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117767 Phase 3 Terbinafine hydrochloride (HCl);Griseofulvin
4 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117754 Phase 3 Terbinafine hydrochloride
5 Design and Clinical Evaluation of a School Meal With Deworming Properties Completed NCT02725255 Phase 2, Phase 3 Albendazole
6 Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis Recruiting NCT02550496 Phase 3
7 The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis Completed NCT02448082 Phase 2
8 Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai Completed NCT02238912 Phase 2 kandhaga rasayanam
9 Safety and Efficacy of NAFT900 in Children With Tinea Capitis Withdrawn NCT02658292 Phase 2 Naftifine hydrochloride foam, 3%;Vehicle
10 Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm) Completed NCT00127868 Not Applicable oral griseofulvin, selenium sulfide shampoo 1%, ciclopirox shampoo , ketoconazole shampoo 2%, baby shampoo
11 The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation Completed NCT00224926
12 Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba Active, not recruiting NCT03443765

Search NIH Clinical Center for Scalp Dermatosis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: scalp dermatoses

Genetic Tests for Scalp Dermatosis

Anatomical Context for Scalp Dermatosis

MalaCards organs/tissues related to Scalp Dermatosis:

41
Skin, Bone

Publications for Scalp Dermatosis

Articles related to Scalp Dermatosis:

# Title Authors Year
1
A 9-month-old infant with severe scalp dermatosis. ( 27543241 )
2016

Variations for Scalp Dermatosis

Expression for Scalp Dermatosis

Search GEO for disease gene expression data for Scalp Dermatosis.

Pathways for Scalp Dermatosis

GO Terms for Scalp Dermatosis

Sources for Scalp Dermatosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....